The U.S. saw a proper drop in deaths as COVID-19's impact that still seem less, but other...
Latest Update
US FDA Approves Novartis’ Fabhalta for IgA Nephropathy, Showing 44% Reduction in Urine Protein Levels.
The FDA's approval of the Shield blood test gives a new screening option for the colon cancer,...
